Use of laser capture microdissection allows detection of loss of heterozygosity in chromosome 9p in breast cancer

Dias,Margarida  Figueiredo; Blumenstein,Robert; Russo,Jose

doi:10.3892/ol.2017.5892

Use of laser capture microdissection allows detection of loss of heterozygosity in chromosome 9p in breast cancer

Authors:
- Margarida Figueiredo Dias
- Robert Blumenstein
- Jose Russo
View Affiliations

Affiliations: Departamento de Ginecologia, Centro Hospitalar da Universidade de Coimbra, Coimbra 3000‑375, Portugal, DeSales University, Allentown, Center Valley, PA 18034, USA, Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Published online on: March 22, 2017 https://doi.org/10.3892/ol.2017.5892
Pages: 3831-3836

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study was designed to determine whether loss of heterozygosity (LOH) in the p arm of chromosome 9 in invasive ductal carcinoma of the breast is detected during the neoplastic progression of the disease. Using laser capture microdissection (LCM) epithelial cells were isolated from 14 invasive ductal carcinoma cases (IDC), ductal carcinomas in situ (DCIS), normal mammary lobules, skin and/or lymph nodes of paraffin embedded tissue sections. LOH analysis of chromosome 9p was performed utilizing the microsatellite markers D9S199, D9S157, D9S171, D9S265 and D9S270. The highest frequency of LOH was observed in invasive ductal carcinomas, which reached a maximum at the 9p22‑23 chromosomal location (D9S157). In addition, DCIS lesions presented a high frequency of LOH in 9p22‑23 (D9S157), followed by 9p21 (D9S171), D9S199 and D9S265, which were similar in frequency to those observed in IDC. A novel finding was the intralesional heterogeneity in LOH within the same DCIS or IDC case. This is an indication that clones of cells that differ in genetic composition coexist in the same lesion. Notably, phenotypically normal breast tissues adjacent to IDC or DCIS exhibited LOH at D9S157 and/or D9S171. Together, these data indicate that LOH of chromosome arm 9p occurs very early in the progression of cancer and that different clones of cells co‑exist within a single tumor.

View Figures

View References

1	Russo J, Yang X, Hu YF, Bove BA, Huang Y, Silva ID, Tahin Q, Wu Y, Higgy N, Zekri A and Russo IH: Biological and molecular basis of human breast cancer. Front Biosci. 3:D944–D960. 1998. View Article : Google Scholar : PubMed/NCBI
2	Werner M, Mattis A, Aubele M, Cummings M, Zitzelsberger H, Hutzler P and Höfler H: 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast. Virchows Arch. 435:469–472. 1999. View Article : Google Scholar : PubMed/NCBI
3	Harris JR and Hellman S: Natural history of breast cancerDiseases of the Breast. Harris JR, Lippman ME, Morrow M and Hellman S: Lippincott Raven; Philadelphia, PA: pp. 375–391. 1996
4	Lakhani SR: The transition from hyperplasia to invasive carcinoma of the breast. J Pathol. 187:272–278. 1999. View Article : Google Scholar : PubMed/NCBI
5	Werner M, Mattis A, Aubele M, Cummings M, Zitzelsberger HH, Hhutzler P and Höfler H: 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast. Virchows Arch. 435:469–472. 1999. View Article : Google Scholar : PubMed/NCBI
6	Eiriksdottir G, Sigurdsson A, Jonasson JG, Agnarsson BA, Sigurdsson H, Gudmundsson J, Bergthorsson JT, Barkardottir RB, Egilsson V and Ingvarsson S: Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regions. Int J Cancer. 64:378–382. 1995. View Article : Google Scholar : PubMed/NCBI
7	Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP and Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57:1597–1604. 1997.PubMed/NCBI
8	Fujii H, Marsh C, Cairns P, Sidransky D and Gabrielson E: Genetic divergence in the clonal evolution of breast cancer. Cancer Res. 56:1493–1497. 1996.PubMed/NCBI
9	Czerniak B, Chatuverdi V, Li L, Hodges S, Johnston D, Ro JY, Luthra R, Logothetis C, Von Eschenbach AC, Grossman HB, et al: Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: Implications for a genetic model of multistep carcinogenesis and early detection of urinary bladder cancer. Oncogene. 18:1185–1196. 1999. View Article : Google Scholar : PubMed/NCBI
10	Campbell IG, Foulkes WD, Beynon G, Davis M and Englefield P: LOH and mutation analysis of CDKN2 in primary human ovarian cancers. Int J Cancer. 63:222–225. 1995. View Article : Google Scholar : PubMed/NCBI
11	Nakanishi H, Wang XL, Imai FL, Kato J, Shiiba M, Myia T, Imai Y and Tanzawa H: Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer. Anticancer Res. 19:29–34. 1999.PubMed/NCBI
12	Murphy DS, Hoare SF, Going JJ, Mallon EE, George WD, Kaye SB, Brown R, Black DM and Keith WN: Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst. 87:1694–1704. 1995. View Article : Google Scholar : PubMed/NCBI
13	Berns EM, Klijn JG, Smid M, Van Staveren IL, Gruis NA and Foekens JA: Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer. Br J Cancer. 72:964–967. 1995. View Article : Google Scholar : PubMed/NCBI
14	Quesnel B, Fenaux P, Philippe N, Fournier J, Bonneterre J, Preudhomme C and Peyrat JP: Analysis of p16 gene deletion and point mutation in breast carcinoma. Br J Cancer. 72:351–353. 1995. View Article : Google Scholar : PubMed/NCBI
15	Xu L, Sgroi D, Sterner CJ, Beauchamp RL, Pinney DM, Keel S, Ueki K, Rutter JL, Buckler AJ and Louis DN: Mutational analysis of CDKN2 (MTS1/p16INK4) in human breast carcinomas. Cancer Res. 54:5262–5264. 1994.PubMed/NCBI
16	Brenner AJ and Aldaz M: Chromosome 9p allelic loss and p16/CDK_N2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res. 55:2892–2895. 1995.PubMed/NCBI
17	An HX, Niederacher D, Picard F, Van Roeyen C, Bender HG and Beckmann MW: Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. Genes Chromosomes Cancer. 17:14–20. 1996. View Article : Google Scholar : PubMed/NCBI
18	Minobe K, Onda M, Iida A, Kasumi F, Sakamoto G, Nakamura Y and Emi M: Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer. Jpn J Cancer Res. 89:916–922. 1998. View Article : Google Scholar : PubMed/NCBI
19	Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Heath J, Jenkins R, Westra W, et al: Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet. 11:210–212. 1995. View Article : Google Scholar : PubMed/NCBI
20	Dutrilaux B, Gerbault-Senreau M and Zafrani B: Characterization of chromosomal abnormalities in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet. 49:203–217. 1990.PubMed/NCBI
21	Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA and Liotta LA: Laser capture microdissection. Science. 274:998–1001. 1996. View Article : Google Scholar : PubMed/NCBI
22	Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S and Liotta LA: Laser capture microdissection: Molecular analysis of tissue. Science. 278:1481–1483. 1997. View Article : Google Scholar : PubMed/NCBI
23	Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR and Liotta LA: Laser capture microdissection: Opening the microscopic frontier to molecular analysis. Trends Genet. 14:272–276. 1998. View Article : Google Scholar : PubMed/NCBI
24	Russo J and Russo IH: The pathology of breast cancer: Staging and prognostic indicators. J Am Med Womens Assoc (1972). 47:181–187. 1992.PubMed/NCBI
25	Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR and van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest. 62:244–278. 1990.PubMed/NCBI
26	Kellogg DE, Rybalkin I, Chen S, Mukhamedova N, Vlasik T, Siebert PD and Chenchik A: TaqStart Antibody: ‘hot start’ PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques. 16:1134–1137. 1994.PubMed/NCBI
27	Wu Y, Barnabas N, Russo IH, Yang X and Russo J: Microsatellite instability and loss of heterozygosity in chromosomes 9 and 16 in human breast epithelial cells transformed by chemical carcinogens. Carcinogenesis. 18:1069–1074. 1997. View Article : Google Scholar : PubMed/NCBI
28	Muzeau F, Flejou JF, Thomas G and Hamelin R: Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. Int J Cancer. 72:27–30. 1997. View Article : Google Scholar : PubMed/NCBI
29	Morita R, Fujimoto A, Hatta N, Takehara K and Takata M: Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. J Invest Dermatol. 111:919–924. 1998. View Article : Google Scholar : PubMed/NCBI
30	Deng G, Lu Y, Zlotikov G, Thor AD and Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science. 274:2057–2059. 1996. View Article : Google Scholar : PubMed/NCBI
31	Nowell PC: The clonal evolution of tumor cell populations. Science. 194:23–28. 1976. View Article : Google Scholar : PubMed/NCBI
32	Fialkow PJ: Clonal origin of human tumors. Biochem Biophys Acta. 458:283–321. 1976.PubMed/NCBI
33	Noguchi S, Motomura K, Inaji H, Imaoka S and Koyamma H: Clonal analysis of human breast cancer by means of the polymerase chain reaction. Cancer Res. 52:6594–6597. 1992.PubMed/NCBI
34	Teixeira MR, Pandis N, Bardi G, Andersen JA, Mitelman F and Heim S: Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients. Int J Cancer. 63:63–68. 1995. View Article : Google Scholar : PubMed/NCBI
35	Teixeira MR, Pandis N, Bardi G, Andersen JA and Heim S: Karyotypic comparisons of multiple tumors and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res. 56:855–859. 1996.PubMed/NCBI
36	Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N and Mitelman F: Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosomes Cancer. 12:173–185. 1995. View Article : Google Scholar : PubMed/NCBI
37	Böni R, Matt D, Voetmeyer A, Burg G and Zhuang Z: Chromosomal allele loss in primary melanoma is heterogeneous and correlates with proliferation. J Invest Dermat. 110:215–217. 1998. View Article : Google Scholar
38	Ornstein DK, Englert C, Gillespie JW, Paweletz CP, Linehan WM and Emmert-Buck MR and Petricoin EF III: Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin Cancer Res. 6:353–356. 2000.PubMed/NCBI
39	Milchgrub S, Wistuba II, Kim BK, Rutherford C, Urban J, Cruz PD Jr..Gazdar AF: Molecular identification of metastatic cancer to the skin using laser capture microdissection: A case report. Cancer. 88:749–754. 2000. View Article : Google Scholar : PubMed/NCBI
40	Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, Höfler H and Werner M: Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet. 110:94–102. 1999. View Article : Google Scholar : PubMed/NCBI
41	Zhuang Z, Merino MJ, Chuaqui R, Liotta LA and Emmert-Buck MR: Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res. 55:467–471. 1995.PubMed/NCBI
42	Radford DM, Phillips NJ, Fair KL, Ritter JH, Holt M and Donis-Keller H: Allelic loss and the progression of breast cancer. Cancer Res. 55:5180–5183. 1995.PubMed/NCBI